Loxo Oncology (LOXO) Reports Q3 Loss of $2.26/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. BA
6. SPY
7. META
8. HOOD
9. INTC
10. JBLU

Go back to Loxo Oncology (LOXO) Reports Q3 Loss of $2.26/Share

Loxo Oncology (LOXO) PT Lowered to $185 at Oppenheimer

November 8, 2018 10:51 AM EST

Oppenheimer analyst Leah Rush Cann lowered the price target on Loxo Oncology (NASDAQ: LOXO) to $185.00 (from $202.00) while maintaining a Outperform rating.

Cann commented, "Loxo's lower than estimated 3Q18 loss resulted from net collaboration revenue recognition of $42.5 million. This, in turn, arose from $52.9 million in... More